Characterization of subcutaneous Contramid implantation: host response and delivery of a potent analog of the growth hormone-releasing factor.
- 1 January 2002
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 232 (1) , 119-129
- https://doi.org/10.1016/s0378-5173(01)00912-7
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Evaluation of starch–maltodextrin–Carbopol® 974 P mixtures for the nasal delivery of insulin in rabbitsJournal of Controlled Release, 2000
- Human Growth Hormone and Human AgingEndocrine Reviews, 1993
- Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old menJournal of Clinical Endocrinology & Metabolism, 1992
- Morphologic examination of rabbit nasal mucosa after nasal administration of degradable starch microspheresInternational Journal of Pharmaceutics, 1991
- Characterization of degradable starch microspheres as a nasal delivery system for drugsInternational Journal of Pharmaceutics, 1990
- Insulin-like growth factor-I concentration in Holstein female cattle: variations with age, stage of lactation and growth hormone-releasing factor administrationDomestic Animal Endocrinology, 1990
- Degradable starch microspheres as a nasal delivery system for insulinInternational Journal of Pharmaceutics, 1988
- Macrophage Stimulation with Some Structurally Related PolysaccharidesScandinavian Journal of Immunology, 1987
- Biodegradable Microspheres V: Stimulation of Macrophages with Microparticles Made of Various PolysaccharidesJournal of Pharmaceutical Sciences, 1987
- Biomaterial biocompatibility and the macrophageBiomaterials, 1984